Basit öğe kaydını göster

dc.contributor.authorLeblebicioglu, H
dc.contributor.authorEroglu, C
dc.contributor.authorAribas, E
dc.contributor.authorSirmatel, F
dc.contributor.authorAyaz, C
dc.contributor.authorOzsoy, MF
dc.contributor.authorOzgenc, O
dc.date.accessioned2020-06-21T15:38:58Z
dc.date.available2020-06-21T15:38:58Z
dc.date.issued2004
dc.identifier.issn1198-743X
dc.identifier.issn1469-0691
dc.identifier.urihttps://doi.org/10.1111/j.1469-0691.2004.00871.x
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21460
dc.description42nd Interscience Conference on Antimicrobial Agents and Chemotherapy -- SEP 26-30, 2002 -- SAN DIEGO, CAen_US
dc.descriptionSaltoglu, Nese/0000-0003-4239-9585; Leblebicioglu, Hakan/0000-0002-6033-8543; dokmetas, ilyas/0000-0003-3523-3923; Ersoy, Yasemin/0000-0001-5730-6682en_US
dc.descriptionWOS: 000221932100007en_US
dc.descriptionPubMed: 15191382en_US
dc.description.abstractThe aim of this study was to investigate the prevalence of hepatitis B virus (HBV) genotypes in Turkey. Epidemiological and clinical data for 158 patients with acute HBV infection from 22 medical centres in the period February 2001 to February 2002 were collected prospectively. HBV genotyping was based on analysis of restriction fragment length polymorphisms and nested PCR. There were 59 female and 99 male patients, with a mean age of 34.2 +/- 15.6 years. The most common probable transmission route was blood contact in 63 (41.1%) cases, but was unknown in 78 (49.4%) cases. The mean alanine aminotransferase level was 1718 +/- 1089 IU/L. Four of the 158 patients (2.5%) died because of fulminant hepatitis. One year after discharge, 11 (10.6%) of 103 cases were positive for hepatitis B surface antigen (HBsAg) and 80 (77.7%) were positive for anti-HBsAg. Genotype determination was unsuccessful in 11 cases because of a negative PCR; genotype D was found in the remaining 147 cases. The results suggested that acute HBV infection constitutes a significant health problem in Turkey and that genotype D is predominant.en_US
dc.language.isoengen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.isversionof10.1111/j.1469-0691.2004.00871.xen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectacute infectionen_US
dc.subjectgenotypeen_US
dc.subjecthepatitis B virusen_US
dc.subjecthepatitis D virusen_US
dc.subjectviral hepatitisen_US
dc.titleAcute hepatitis B virus infection in Turkey: epidemiology and genotype distributionen_US
dc.typeconferenceObjecten_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume10en_US
dc.identifier.issue6en_US
dc.identifier.startpage537en_US
dc.identifier.endpage541en_US
dc.relation.journalClinical Microbiology and Infectionen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster